Total planned funding: $292,549,038
Allocations
Countries/Regions
| India | $292,549,038 |
Organizational Types
| Unknown | $114,640,124 |
| NGO | $90,770,500 |
| Own Agency | $44,157,222 |
| University | $25,282,112 |
| Multi-lateral Agency | $4,816,808 |
| Private Contractor | $4,098,272 |
| Implementing Agency | $3,100,000 |
| FBO | $2,700,000 |
| Host Country Government Agency | $1,949,400 |
| Other USG Agency | $1,034,600 |
Program Areas
| Governance and Systems | $116,048,756 |
| Prevention | $71,902,564 |
| Care | $38,785,767 |
| Management and Operations | $32,764,731 |
| Testing | $15,189,593 |
| Treatment | $13,429,835 |
Budget Codes
| OHSS: Health Systems Strengthening | $66,624,503 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $39,221,250 |
| HVSI: Strategic Information | $38,447,046 |
| HVMS: Management and Operations | $32,764,731 |
| HBHC: Care: Adult Care and Support | $24,920,784 |
| HVCT: Testing: HIV Testing and Counseling | $15,189,593 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,678,931 |
| HTXS: Treatment: Adult Treatment | $12,628,210 |
| HLAB: Laboratory Infrastructure | $10,977,207 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,874,012 |
| HKID: Care: Orphans and Vulnerable Children | $7,463,291 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,515,097 |
| HVTB: Care: TB/HIV | $5,445,623 |
| HMBL: Biomedical Prevention: Blood Safety | $3,603,274 |
| PDCS: Care: Pediatric Care and Support | $956,069 |
| PDTX: Treatment: Pediatric Treatment | $778,148 |
| HTXD: Treatment: ARV Drugs | $23,477 |
| HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$112,968,146
Countries/Regions
FHI 360:
$29,164,882
Countries/Regions
USG Aggregated Agencies:
$27,635,624
Countries/Regions
Voluntary Health Services:
$17,340,000
Countries/Regions
University of Manitoba:
$13,592,112
Countries/Regions